Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000769993-20-000083
Filing Date
2020-01-31
Accepted
2020-01-31 16:25:23
Documents
1
Group Members
GOLDMAN SACHS & CO. LLC

Document Format Files

Seq Description Document Type Size
1 13G NEOS THERAPEUTICS 13G_NeosTherapeutics.txt SC 13G 21887
  Complete submission text file 0000769993-20-000083.txt   23589
Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 212-902-1000
GOLDMAN SACHS GROUP INC (Filed by) CIK: 0000886982 (see all company filings)

EIN.: 134019460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Subject) CIK: 0001467652 (see all company filings)

EIN.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88949 | Film No.: 20565398
SIC: 2834 Pharmaceutical Preparations